Business Context and Reporting Period
This Form 8-K Current Report was filed by Standard BioTools Inc. (Nasdaq: LAB) on April 28, 2023. The report addresses a corporate governance event regarding the Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a specific corporate event and does not contain financial performance data.
Material Changes
The material change reported is the departure of a director:
- Gerhard Burbach, a member of the Board of Directors, notified the Board of his intent to retire.
- His retirement from the Board, the Nominating and Corporate Governance Committee, and the Compensation Committee is effective immediately following the Company's 2023 annual meeting of stockholders on June 14, 2023.
- The departure is consistent with the Company's corporate governance principles regarding limited tenure and is not due to any disagreement with the Company or the Board.
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, or management commentary regarding future financial performance. No new risks, contingencies, or unusual items were disclosed in this report.
Key Facts for Investor Verification
- Gerhard Burbach will retire from the Board effective June 14, 2023.
- Mr. Burbach served on the Board for ten years.
- The retirement is voluntary and unrelated to any operational or policy disagreements.
- The Company has not announced a replacement director in this filing.